Background: Atrial fibrillation (AF) is a prevalent and chronic cardiovascular disorder associated with various pathophysiological alterations, including atrial electrical and structural remodeling, disrupted calcium handling, autonomic nervous system dysfunction, aberrant energy metabolism, and immune dysregulation. Emerging evidence suggests that long non-coding RNAs (lncRNAs) play a significant role in the pathogenesis of AF. Objective: This discussion aims to elucidate the involvement of AF-related lncRNAs, with a specific focus on their role as miRNA sponges that modulate crucial signaling pathways, contributing to the progression of AF. We also address current limitations in AF-related lncRNA research and explore potential future directions in this field. Additionally, we summarize feasible strategies and promising delivery systems for targeting lncRNAs in AF therapy. Conclusion: In conclusion, targeting AF-related lncRNAs holds substantial promise for future investigations and represents a potential therapeutic avenue for managing AF.
CITATION STYLE
Zhong, Z., Li, X., Gao, L., Wu, X., Ye, Y., Zhang, X., … Liu, S. (2023). Long Non-coding RNA Involved in the Pathophysiology of Atrial Fibrillation. Cardiovascular Drugs and Therapy. Springer. https://doi.org/10.1007/s10557-023-07491-8
Mendeley helps you to discover research relevant for your work.